
Healthcare London to visit Riyadh for clinically-led trade mission
Riyadh, Saudi Arabia: Healthcare London, a collaboration of leading private healthcare providers and teaching hospitals, is sending a delegation to Riyadh from 11–13 May 2025 to strengthen partnerships and expand access to world-class care for Saudi patients.
This marks Healthcare London's second delegation to Saudi Arabia. The first visit, in April 2024, saw the successful launch of Healthcare London at the Health Tourism Future Forum in Riyadh.
Building on this momentum, the May 2025 mission will focus on clinically-led engagement—connecting top referring clinicians in Saudi Arabia with London-based experts in highly specialised fields, including proton beam therapy and paediatric heart surgery.
Michael Barker, Project Director for Healthcare London, said:
"Our partners are recognised for their expertise and innovation, and together, we are creating an unique healthcare destination for patients seeking the best in medical care. London brings together top medical talent, expertise and resources to deliver unparalleled treatments and services for patients from Saudi Arabia, the MENA region and beyond."
Clinically focused events to strengthen collaboration
During the three-day trade mission, Healthcare London will host two flagship events:
A Clinical Forum, in partnership with the Saudi Medical Appointments and Referral Centre, where London's leading clinicians will present case studies and share insights into the latest innovations in complex care and patient outcomes.
A formal reception at the British Embassy in Riyadh, welcoming senior figures from across Saudi Arabia's health system. The evening will provide a platform for strengthening relationships, exchanging knowledge and exploring future collaboration opportunities.
The delegation will also meet with leading hospital groups in Riyadh to further build partnerships and an exchange of ideas.
A world-class healthcare offering
The Healthcare London partners include:
Chelsea and Westminster Hospital Private Care (NHS)
Cleveland Clinic London
Cromwell Hospital
HCA Healthcare UK
King Edward VII's Hospital
Imperial College Healthcare Private Care (NHS)
Phoenix Hospital Group
The London Clinic
University College London Hospitals Private Healthcare (NHS)
Proton International London
The London Psychiatry Clinic
Priory
Together, these providers form a unified voice for the London's exceptional healthcare ecosystem. Each year, over 100,000 overseas patients choose London for its depth of medical expertise and comprehensive range of complex care services.
London offers the highest concentration of medical and surgical specialists of any city globally. From cutting-edge diagnostics to advanced surgical procedures, its hospitals are internationally recognised for innovation and excellence in patient care. Many also lead the way in telehealth and virtual care, ensuring continuity of treatment for international patients both before and after travel.
"Healthcare London's partners are committed to sharing expertise with Saudi clinicians through training programmes, in-country support and staff exchanges in London," added Barker.
"This collaborative approach aims to raise standards of care and support the Kingdom's ambitious healthcare transformation goals."
Healthcare London is formed by the following partner organisations.
Chelsea and Westminster Hospital Private Care (NHS unit)
Chelsea and Westminster Hospital NHS Foundation Trust was established in 1876. It provides a range of services from its main base in Chelsea and via a number of clinics across London and the Southeast of England. Recognised as one of the UK's best performing and top ranked NHS Foundation Trusts, they are regularly heading the NHS league tables in many areas.
Cleveland Clinic London
As part of one of the world's top ranked hospital systems, Cleveland Clinic London provides patients with access to a global network of physicians and specialists dedicated to offering the highest quality care. Cleveland Clinic London comprises a 184-bed state-of the-art hospital, at 33 Grosvenor Place in central London, Portland Place Outpatient Centre in the Harley Street Medical Area, and Moorgate Outpatient Centre, in the City of London.
Cromwell Hospital
Cromwell Hospital was established in 1981 and acquired by Bupa, leading international healthcare group, in March 2008. It is a leading London hospital renowned for being the first to invest in some of the UK's leading edge equipment and cancer services. Based in West London, the hospital has over 500 accredited consultants, mainly drawn from London's teaching hospitals, covering over 70 specialties. It is recognised as a centre of excellence for oncology, cardiology, paediatrics, orthopaedics, lung, complex surgery, and medicine. Cromwell Hospital's diagnostics service offers the very latest technology. There are two ambient MRI scanners and the angiography suite offers the most up-to-date imaging available in London.
HCA Healthcare
HCA UK has six internationally renowned private hospitals in London that are supported by a range of outpatient and diagnostic facilities. Our London hospitals, including The Portland Hospital, the UK's only private hospital dedicated to the care of women and children, are a destination of choice for patients looking for excellent clinical care At HCA Healthcare UK, its clinical teams work together to provide patient-centred, holistic treatment across multiple care specialties, including paediatrics, oncology, cardiology, orthopaedics and women's health.
Imperial College Healthcare Private Care (NHS unit)
Imperial College Healthcare Private Care is part of a leading London NHS Trust offering consultant
led care, supported by dedicated multi-disciplinary teams. It provides access to exceptional clinical
care and expertise within some of London's most respected NHS teaching hospitals. They provide
private services across every medical, diagnostic and surgical speciality, and its close partnership with
Imperial College London, a leading UK University, allows consultants to quickly translate research into
practice, meaning patients receive the most up-to-date treatment. All funds generated by private care
services reinvested back into the Trust to support both NHS and private services.
King Edward VII's Hospital
Founded in 1899, King Edward VII's Hospital is an independent charitable hospital internationally recognised for delivering exceptional surgical and clinical care. Situated in London's prestigious Harley Street medical district, its hospital boasts a rich history of Royal Patronage and provides tailored diagnostic, inpatient and outpatient services to UK and international patients. With a focus on women's health, urology, digestive health and musculoskeletal services, they offer comprehensive healthcare solutions tailored to individual needs.
Priory
Priory has an extensive network of private hospitals and wellbeing centres across
Greater London, including the world-famous Priory Hospital Roehampton – offering fast
access to the best possible treatment, from leading experts. Their multidisciplinary team of therapists, psychologists and psychiatrists have expertise in treating a wide variety of conditions, including addictions, eating disorders, depression, anxiety and obsessive compulsive disorder (OCD), alongside providing an autism assessment and diagnosis service. The Cottage at Life Works, Woking, provides the UK's most exclusive and unique treatment experience, treating just one client at a time.
Proton International London
Proton International London works with leading cancer specialists from across London and the rest of the UK to ensure that cancer patients who will genuinely benefit from proton beam therapy
can access it – regardless of where they have been treated previously or where they have
been seen as an outpatient. With over 30 years' experience in treating patients with proton beam therapy (PBT) in the USA, Proton International brings unmatched experience and expertise in providing this advanced and extremely precise treatment to people with cancer in communities across the world.
Phoenix Hospital Group
Located in the heart of the Harley Street Medical Precinct, Phoenix Hospital Group is renowned for providing exceptional patient care in a luxury healthcare setting. At the forefront of preventative health and cancer screening, its dedicated Outpatient & Diagnostic Centres are recognised for exceptional imaging & diagnostic capabilities. Phoenix Hospital Group was established in 2007 with the intention of providing first class specialist healthcare services within a luxury environment.
The London Clinic
The London Clinic is the UK's largest independent hospital with charitable status. The world-class Harley Street hospital has an almost 100-year history and treats over 195,000 patients a year, specialising in oncology, haematology, ophthalmology and orthopaedics. In 2024 they opened a new Rapid Diagnostics Centre to drive early diagnosis and better outcomes, and announced a ground-breaking international collaboration with Northwestern Medicine, a US academic healthcare organisation. International patients are an integral part of the Clinic's patient community and there is a dedicated International Office to care for them every step of their journey.
The London Psychiatry Clinic
The London Psychiatry Clinic is a private outpatient mental health clinic with a strong focus
on wellness and a progressive and high-quality approach to mental health and wellbeing.
Their mission is to create a safe, confidential and empathetic environment founded
on principles of profound respect and compassion for each individual. Excellence is
at the core of the London Psychiatry Clinic and its approach is evidence-based and holistic.
UCLH Private Healthcare
UCLH Private Healthcare blends NHS expertise with private care benefits. As part of University College London Hospitals NHS Foundation Trust, many of its world-class consultants hold dual roles with University College London, advancing research into pioneering treatments. University College Hospital specialises in stem cell transplants, CAR-T therapy, and proton beam therapy, and houses the UK's largest teenage and young adult cancer service. The National Hospital for Neurology and Neurosurgery, in Queen Square, is a leading specialist centre for advanced neurosurgery and neurological care.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


TECHx
a day ago
- TECHx
Why Generative AI Isn't a Silver Bullet for Healthcare
Home » Smart Sectors » Healthcare » Why Generative AI Isn't a Silver Bullet for Healthcare Generative AI is revolutionizing healthcare, but challenges remain. Ashley Woodbridge, Lenovo CTO META, explores why it's no silver bullet. The healthcare sector is on the brink of a significant surge in AI investment, projected to rise by an astounding 169% over the next year – the highest increase among all industries surveyed in EMEA. The uptick follows the promising early results of AI projects, where a remarkable 74% of healthcare AI pilot projects have met or exceeded expectations, with 13% surpassing them. Yet, despite this positive momentum, only 2% of healthcare organisations have actively deployed AI at scale with the majority of initiatives remaining in the pilot or planning stages. This raises the question: how can the industry and its partners move beyond this plateau? What is Generative AI Doing? For most people, their experience of Generative AI (GenAI), has been through conversations with chatbots, creating new content or summarising data. These lighter use cases have highlighted numerous challenges that must be addressed before widespread adoption can occur, especially in highly regulated industries like healthcare. One of the primary obstacles identified in the region wide survey is data quality. AI models, including GenAI, are only as effective as the data they are trained on. In healthcare, data often exists in silos, across incompatible systems, and in formats that are difficult to interpret. There are also important patient data privacy considerations to take into account. Despite the complexity involved in sorting and standardising this data, the potential benefits of tackling these issues and making it useable by AI are immense. For example, tools like Epic's 'Slicerdicer' allow healthcare professionals to query large datasets through conversational interfaces, uncovering important trends in patient outcomes and informing better care. The depth of queries is particularly powerful, allowing healthcare providers to uncover trends amongst patients that share a condition or illness that may have otherwise remained hidden. Taking the technology in a different direction, AI-powered 'ambient digital scribes' are being trialled by NHS doctors in the UK. These systems listen to patient appointments and automatically generate clinical notes, saving hours of administrative work and helping to reduce burnout among medical staff. However, healthcare providers must tread carefully. Public sentiment towards AI in healthcare remains cautious. Only 28% of people aged over 60 feel comfortable with AI technologies being used in their care, and 75% of consumers overall want to be informed if AI is being used in their healthcare communications. Transparency is critical. For AI to enhance patient experience without undermining it, trust must be maintained. In countries like the UAE and Saudi Arabia, AI algorithms are enhancing radiology by assisting in the analysis of medical images, enabling quicker and more accurate detection of conditions such as lung cancer. Predictive analytics are being utilized for real-time patient monitoring, allowing healthcare providers to intervene early in critical situations. Generative AI is also making strides in drug discovery, particularly in Qatar, where researchers are modelling molecular interactions to accelerate the development of new therapies. Additionally, AI-powered chatbots and virtual health assistants are streamlining telemedicine services, providing preliminary diagnoses and scheduling appointments, thus improving access to care. AI's Role in Medical Research Beyond frontline care, GenAI is turbocharging work in the field of medical research. Earlier this year, a researcher at Imperial College London used an AI tool developed by Google to investigate why certain bacteria are resistant to antibiotics. In just 48 hours, the tool proposed four viable hypotheses, whereas it had taken scientists over a decade to finalise just a single hypothesis manually. The result was so astonishing that the original researcher initially suspected the AI had accessed unpublished work on his personal computer, which was proven not to have been the case. These breakthroughs are being made possible thanks to the high-performance computing systems behind increasingly powerful AI models. At Lenovo, we are proud to partner with the Broad Institute on genome analysis, helping researchers accelerate one of the most data-intensive tasks in science. The Lenovo Genomics Optimization and Scalability Tool (GOAST) reduces the time needed to analyse a whole human genome from over 100 hours to just 47 minutes. Other organizations are also harnessing advanced AI and computing tools to push the boundaries of healthcare. Hungarian company 3DHISTECH, for example, uses Lenovo's AMD Threadripper-powered ThinkStation P620 workstations to build detailed 3D virtual models of human and non-human tissue. These models can zoom in to the level of individual chromosomes, enabling new frontiers in digital pathology. Their systems are used by institutions around the world, including Harvard Medical School, Novartis, and the Wuhan Institute of Virology. Notably, a 3DHISTECH system played a pivotal role in diagnosing the first COVID-19 patient in China, demonstrating how AI-enabled technology can impact global health crises. The Human Element Remains Crucial While AI offers compelling advantages, it's important to remember that technology alone isn't the answer. The human touch in healthcare remains indispensable. Healthcare providers must ensure transparency in their AI implementations and address data quality issues to fully reap the benefits of AI. By doing so, they can enhance patient care, reduce burnout among medical staff, and drive groundbreaking research, all without sacrificing the trust and comfort of those they serve. In conclusion, the healthcare industry stands at the brink of an AI-driven revolution. With thoughtful implementation and a focus on maintaining trust, AI has the potential to transform healthcare for the better. The journey won't be without its challenges, but the rewards promise to be well worth the effort. By Ashley Woodbridge, CTO, Lenovo, META


Arabian Post
2 days ago
- Arabian Post
Tanoto Foundation Backs Landmark Research to Unlock the Code of Asian Prevalent Diseases
Understanding Asian Cancers and Diabetes Through an Asian Lens SINGAPORE – Media OutReach Newswire – 27 June 2025 – Tanoto Foundation today announced the funding of two transformative, Singapore-based medical research projects focused on diseases that disproportionately affect Asian populations: prevalent and aggressive cancers, and young-onset Type 2 diabetes. The multi-year initiatives aim to generate data-driven insights that can accelerate diagnosis, improve patient outcomes, and guide public health policy. NCCS and SGH secure research funding from Tanoto Foundation for projects tackling Asian-prevalent cancers and young-onset diabetes to drive breakthroughs in regional health Despite global strides in medicine, Asia continues to face rising rates of cancer and diabetes – diseases that are biologically and clinically distinct in Asian populations but remain under-researched due to a lack of region-specific data. The two research projects, from National Cancer Centre Singapore and Singapore General Hospital, will focus on filling these gaps through deep genomic studies and innovative risk-prediction models. ADVERTISEMENT Imelda Tanoto, Member of the Board of Trustees, Tanoto Foundation said: 'Singapore is well-positioned to lead in medical science. It has strong research institutions and a population that reflects the diversity of Asia. By supporting researchers here who are focused on health issues that affect Asians, we hope to help drive discoveries that make a real difference to people's lives — both in Singapore and across the region.' Tackling Asian-Prevalent Cancers Led by Dr Jason Chan, Medical Oncologist, National Cancer Centre Singapore, the research will investigate four types of cancers with high prevalence and poor outcomes in Asia: Breast Cancer in Asian Women, marked by earlier onset and biological differences compared to Western populations T/NK-Cell Lymphomas, an aggressive blood cancer dominant in East Asians with limited treatment options Bile Duct Cancer (Cholangiocarcinoma), increasingly linked to environmental exposures specific to Asia Rare Asian Cancers, collectively neglected but accounting for up to 25% of all cases in the region These cancers are devastating but remain poorly understood because most research has focused on Western populations,' said Dr Chan. 'By decoding their molecular and genomic landscapes in Asian patients, we want to uncover new diagnostic and therapeutic opportunities to benefit patients.' A key feature of the project is its open-access commitment: anonymised data will be freely available to the broader research community to accelerate further discovery and collaboration. Unmasking Diabetes Risk in Young Singaporeans The second research project, led by Dr Daphne Gardner, Endocrinologist, Singapore General Hospital, will address the rising incidence of Type 2 diabetes in young adults, particularly prevalent in Singapore, where 1 in 5 young adults have prediabetes or diabetes, despite being of normal weight. ADVERTISEMENT Unlike traditional assessments that rely heavily on BMI and family history, this project will develop a next-generation risk prediction tool by incorporating non-traditional indicators such as body fat distribution, continuous glucose monitoring, and health-seeking behaviour. 'Many young Asians with diabetes don't fit the usual risk profile. They're lean, active, and often overlooked by current screening models,' said Dr Gardner. 'We want to change that by identifying new risk signals and developing tools that are tailored to Singapore's population and beyond.' Findings from the study aim to inform national diabetes screening guidelines and lead to earlier interventions that can curb long-term complications. Singapore as a Hub for Medical Research Advancement In addition to previously supported research projects, these two initiatives reflect a growing recognition of Singapore's role in advancing precision medicine for Asian populations, driven by strong clinical infrastructure, genomic capabilities, and public-private partnerships. Imelda Tanoto added: 'We believe precision health can change how we treat and prevent diseases. We're supporting researchers who are not only breaking new ground, but also making sure their work reaches people and communities across Asia. This is something deeply personal to us — it's about improving lives in a way that's inclusive, meaningful, and lasting.' This announcement marks a key milestone in Tanoto Foundation's continuing effort to improve the quality of healthcare and health standards, leading to longer and better healthspans. Hashtag: #TanotoFoundation The issuer is solely responsible for the content of this announcement. About Tanoto Foundation At Tanoto Foundation, we unlock human potential, help communities thrive, and create lasting impact. Founded in 1981 by Sukanto Tanoto and Tinah Bingei Tanoto, we are an independent family foundation that believes in providing every person with the opportunity to realize his or her full potential. To do so, we catalyse systems change in education and healthcare. Our approach is impact-first, collaborative, and evidence-based. We invest for the long term and strive to develop leaders who can drive sustained, positive outcomes. More information is available at


Gulf Today
3 days ago
- Gulf Today
Six million donkeys slaughtered for Chinese medicine: Charity
Almost six million donkeys are slaughtered annually for Chinese medicine, with severe knock-on effects for African villagers who rely on the animals, a UK-based charity said on Thursday. It is driven by an increase in China's production of ejiao — a product marketed as a health supplement that uses collagen from donkey skins — which is a $6.8-billion industry, according to China-based research firm Qianzhan. China, whose donkey population has plummeted from 11 million in 1992 to 1.5 million in 2023, has turned to Africa to meet its demand. With donkey populations falling, the African Union issued a 15-year moratorium on donkey slaughter last year. UK-based charity The Donkey Sanctuary said "the ejiao industry drives a massive global trade in donkey skins, much of it illegal." It said around 5.9 million donkeys were killed worldwide last year. The ejiao trade is expected to require at least 6.8 million donkey skins by 2027. The rising value of donkeys means they have increasingly become targets for criminals. A man rides a donkey-pulled cart carrying corn husks along the banks of the Rio Bravo after heavy rains, in Ciudad Juarez, Mexico. Reuters "Traders exploit vulnerable people using large and sophisticated networks of agents to pressure donkey owners into selling their animals," the charity said. "Illegal networks operate across the continent, often without consequence, stealing and slaughtering donkeys in the night," it added. "Donkeys die in often unregulated, inhumane, and unsanitary conditions, and large numbers perish on their way to slaughterhouses," it continued. The impact on humans is particularly felt by women and children, who rely on donkeys for farming activities such as ploughing and for carrying goods to market. The criminal operations also generated health risks, The Donkey Sanctuary said. "The transportation of untreated skins and improper disposal of donkey carcasses risk triggering the spread of infectious diseases and damaging local ecosystems." Agence France-Presse